BioNTech SE
BNTX | NASDAQ
$100.87
+$2.87 (+2.93%)
At close: Sep 22, 2026, 4:00 PM ET
$101.99
+$1.12 (+1.11%)
After-hours:
Sep 22, 2026, 7:31 PM ET
Market Data
Market Cap $24.62B
Enterprise Value $12.13B
Beta 1.29
Average Volume 1.12M
Shares Outstanding (Diluted) 253.33M
Shares Change YoY 4.85%
Institutional Ownership 18.79%
Exchange NASDAQ
ISIN US09075V1026
Price Performance
Price Change 1M -14.2%
Price Change 3M 8.1%
Price Change 6M 10.4%
Price Change YTD 1.4%
Price Change 1Y -0.7%
Price Change 3Y -6.3%
Price Change 5Y -70.6%
1M CAGR (ann.) 4.6%
1Y CAGR (ann.) 1.8%
5Y CAGR (ann.) -21.2%
All-Time CAGR 32.2%
Valuation
PE Ratio -12.37
Forward PE N/A
PEG Ratio 0.13
Forward PEG -11.29
PS Ratio 7.98
Forward PS 12.10
PB Ratio 1.21
P/FCF Ratio 40.72
P/Adj. FCF Ratio 40.72
P/OCF Ratio 28.77
EV/Sales 4.59
EV/EBIT -7.98
EV/EBITDA -14.47
EV/FCF 23.41
Earnings Yield -7.9%
FCF Yield 2.4%
Adj. FCF Yield 2.4%
Financial Health
Net Cash €9.42B
Total Debt €315.97M
Cash & Short-Term Investments €9.74B
Total Assets €20.33B
Current Ratio 7.85
Quick Ratio 7.80
Debt / Equity Ratio 0.02
Debt / EBITDA -0.38
Debt / FCF 0.61
OCF / Debt 2.33
Interest Coverage -65.51
Altman Z-Score 6.82
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 69.0%
Operating Profit Margin -64.3%
EBITDA Margin -31.6%
Net Profit Margin -64.3%
FCF Margin 19.6%
Adj. FCF Margin 19.6%
SBC / Revenue 2.8%
SBC Impact (per share) N/A
Returns
Return on Assets -8.3%
Return on Equity -9.2%
Return on Invested Capital -9.3%
Return on Capital Employed -9.3%
Return on Tangible Assets -9.2%
Historical Growth (CAGR)
Revenue CAGR 3Y -34.0%
Revenue CAGR 5Y -19.4%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -66.0%
EPS CAGR 5Y -118.2%
EPS CAGR 10Y N/A
FCF CAGR 3Y -61.0%
FCF CAGR 5Y -73.3%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 24
EPS Growth Next 3Y 11.9%
Revenue Growth Next 3Y -7.7%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) $0.97
EPS Growth Est (next Q) -706.4%
Revenue Est (next Q) $1.39B
Revenue Growth Est (next Q) -31.8%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $121.83
Price Target Upside 24.3%
Cash Flow
Operating Cash Flow €736.83M
Free Cash Flow €518.34M
Adj. Free Cash Flow €518.34M
FCF Per Share $2.05
OCF Per Share $2.92
OCF/S Ratio 27.9%
Income Statement
Revenue €2.65B
Gross Profit €1.7B
Operating Income €-1.7B
EBITDA €-838.31M
Net Income €-1.71B
EPS (Diluted) -$6.79
Revenue / Employee $338.82K
Profit / Employee $-218.51K
Employees 7,807
Add to Watchlist
Select watchlists to add or remove BNTX